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Colonization by Lactobacillus in the female genital
tract is thought to be critical for maintaining genital
health. However, little is known about how genital
microbiota influencehost immune functionandmodu-
late disease susceptibility. We studied a cohort of
asymptomatic young South African women and
found that the majority of participants had genital
communities with low Lactobacillus abundance and
high ecological diversity. High-diversity communities
strongly correlated with genital pro-inflammatory
cytokine concentrations in both cross-sectional and
longitudinal analyses. Transcriptional profiling sug-
gested that genital antigen-presenting cells sense
gram-negative bacterial products in situ via Toll-like
receptor 4 signaling, contributing to genital inflamma-
tion throughactivationof theNF-kBsignalingpathway
and recruitment of lymphocytes by chemokine pro-
duction. Our study proposes a mechanism by which
cervicovaginal microbiota impact genital inflamma-
tion and therebymight affect a woman’s reproductive
health, including her risk of acquiring HIV.
INTRODUCTION
The female genital tract (FGT) maintains a finely-tuned immune
response that balances reproductive tolerance with protectionagainst genital infections. While inflammatory responses are
beneficial and required to effectively eliminate several sexually
transmitted infections (STIs), the presence of elevated genital
inflammation in women prior to HIV exposure paradoxically
increases the risk of disease acquisition (Lajoie et al., 2012; Mas-
son et al., 2015; Morrison et al., 2014). Studies of the microbial
causes of this inflammation have primarily focused on estab-
lished pathogens such asChlamydia trachomatis,Neisseria gon-
orrhoeae, HSV-2, and Trichomonas vaginalis. The potential role
of commensal cervicovaginal bacteria, which number 108 per
gram of vaginal fluid (Delaney and Onderdonk, 2001), in modu-
lating immune responses in the FGT is largely unknown.
The bacterial microbiome of the healthy FGT is thought to be
exceedingly simple, predominated by a single Lactobacillus spe-
cies in the majority of white premenopausal women (Chaban
et al., 2014; Drell et al., 2013; Huttenhower, 2012; Ravel et al.,
2011; Zhou et al., 2007). These lactobacilli benefit the host by in-
hibiting the growth of pathogenic bacteria and fungi through the
production of bacteriocins, lactic acid, and hydrogen peroxide
(Aroutcheva et al., 2001; Ghartey et al., 2014). Bacterial vaginosis
(BV) is an alteration of microbial communities in this ecological
niche in which lactobacilli are replaced byGardnerella andMobi-
luncus species. BV is associated with a 1.5- to 2-fold increased
risk of acquiring C. trachomatis, N. gonorrhoeae, T. vaginalis,
and HIV (Atashili et al., 2008; Brotman et al., 2010), which raises
the question of whether specific genital microbial communities in
asymptomatic women might more broadly modulate disease
susceptibility.
To determine the contribution of cervicovaginal microbiota to
genital inflammation, we evaluated a cohort of asymptomatic
HIV-negative young South African women. Only a minority ofImmunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc. 965
Figure 1. 16S rRNA Sequence Analysis of
Cervical Swabs Reveals Low Lactobacillus
Abundance and Four Distinct Bacterial
Community Structures
(A) Heatmap of bacterial taxa identified by 16S
rRNA V4 sequencing of cervical swabs collected
from 94 women. Cervicotypes (CTs) were deter-
mined based on the dominant species: Lactoba-
cillus crispatus (CT1), L. iners (CT2), Gardnerella
(CT3), and mixed microbial community containing
Prevotella (CT4). Nugent scores and bacterial
alpha diversity are also shown.
(B) Principal coordinates analysis using the
weighted UniFrac distance metric on the same 94
samples, colored by CT.
See also Figure S1 and Table S1.study participants had Lactobacillus-dominant cervicovaginal
communities, despite a lack of clinical symptoms, redefining
what is considered to be normal in this region. We found a strong
in vivo relationship between high-diversity bacterial communities
lacking Lactobacillus dominance and genital pro-inflammatory
cytokine levels. We identified specific bacterial species within
the high-diversity communities that elicit pro-inflammatory cyto-
kines and provide evidence that endocervical antigen-present-
ing cells (APCs) sense microbial lipopolysaccharide (LPS) and
produce myriad pro-inflammatory cytokines and T cell chemoat-
tractants. Our data provide important insight into themechanism
by which bacterial microbiota impact host immunity and suggest
potential interventions to reduce disease susceptibility in women
in sub-Saharan Africa.
RESULTS
A Minority of South African Women in FRESH Have
Lactobacillus Dominant Genital Communities
We began by assessing the baseline bacterial microbiome in
participants from the FRESH (Females Rising through Education,
Support and Health) study, a cohort enrolling HIV-negative, 18-
to 23-year-old, black South African women. Following isolation
of nucleic acid from cervical swabs, we sequenced variable
region 4 (V4) of the bacterial 16S rRNA gene to assess bacterial
abundances (Caporaso et al., 2012) (Figure 1A).We clustered the966 Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc.observed bacterial communities into four
distinct community types based on
the dominant bacterial species, herein
referred to as ‘‘cervicotypes’’ (CTs). CT1
was primarily composed of non-iners
Lactobacillus (i.e., higher percentage of
sequencing reads from non-iners Lacto-
bacillus than L. iners, Gardnerella, or
Prevotella); CT2 was Lactobacillus iners
dominant; CT3 had Gardnerella domi-
nance; and CT4 lacked a consistent
dominant species but communities all
included Prevotella (Figures 1A and S1).
Visualization of the same samples using
a principal coordinates plot, which repre-
sents the phylogenetic distance betweensamples, supported the dominance-based clustering, though
CT3 and CT4 are a continuum (Figure 1B).
We found that only 37% of participants had Lactobacillus
dominant cervicovaginal communities. This is in contrast to pub-
lished reports of white and black women in developed countries
in which 90% and 62% of women respectively demonstrated
Lactobacillus dominance (Ravel et al., 2011; Zhou et al., 2007).
Of those women with Lactobacillus dominance in our study,
77% primarily had Lactobacillus iners (CT2). L. iners is biologi-
cally distinct from other lactobacilli because of its unique adap-
tation to survive with diverse community members (Macklaim
et al., 2013) and greater pathogenic potential (Doerflinger et al.,
2014; Rampersaud et al., 2011).
Of the 63% of women in our cohort who did not have Lacto-
bacillus dominance, 45% had Gardnerella-dominant commu-
nities (CT3). The remaining 55% of women did not have a
consistent predominant bacterial taxon, though each commu-
nity was found to have at least 10% Prevotella abundance
(CT4). Additionally, only half of the women in CT4 had BV, as
measured by the Nugent criteria, which assesses a Gram-
stained vaginal wet prep based on bacterial morphology;
none of these women reported symptoms. Overall, the bacterial
community structures seen in these asymptomatic young South
African women were characterized by a predominance of com-
munities with high ecological diversity and low abundance of
non-iners Lactobacillus.
Figure 2. Close Concordance between
Bacterial Taxa Determinations by 16S
rRNA and Whole-Genome Sequencing
16S rRNA V4 sequencing and whole-genome
shotgun sequencing (WGS) identify very similar
bacterial abundances for all CTs, with higher res-
olution taxonomic identification provided byWGS.
Participant #6 represents CT1 (A), #1 represents
CT2 (B), #7 represents CT3 (C), #11 represents
CT4 (D). See also Figure S2.We next confirmed the 16S rRNA gene sequencing results and
resolved specific community members at a species level by per-
forming whole-genome shotgun sequencing (WGS) on cervical
bacterial DNA from a subset of 12 women representing all four
CTs (Figure S2A). WGS has proven useful for species-level taxo-
nomic resolution when different bacterial species share nearly
identical 16S rRNA variable regions (Jaspers and Overmann,
2004; Segata et al., 2012). The taxonomic classification by WGS
had good agreement with 16S-based classification and STI
PCR results (Figures 2 andS2B). The additional species-level res-
olution provided by WGS also revealed that both of the women
with CT1 analyzed byWGS had Lactobacillus crispatus dominant
microbiota (Figures 2A and S2B). We extended the analysis to
every woman within CT1 by using taxonomic identification by
oligotyping, a method that detects patterns in subtle nucleotide
variations within the 16S rRNA gene (Eren et al., 2011) and found
that nearly all women had identical sequences that aligned to
L. crispatus (Figure S2C), further validating that CT1 was mostly
composed of L. crispatus. We therefore demonstrated close
agreement between taxonomic classifications obtained by 16S
rRNAsequencingandWGSand furtherusedWGStoprovidespe-
cies level resolution of specific bacterial community members.
Cervicovaginal Bacterial Communities Are Not
Associated with Sexually Transmitted Infections,
Hormonal Contraceptive Usage, or Sexual Behavior
Women with BV have been shown to have a higher incidence
and prevalence of sexually transmitted infections (STIs) (Brot-
man et al., 2010; Wiesenfeld et al., 2003), to be less likely to
use hormonal contraceptives (Bradshaw et al., 2013a), and to
bemore likely to engage in high-risk sexual behavior (Bradshaw
et al., 2013b). However, we did not find a difference in the
prevalence of an active STI or STI symptoms between cervico-
types, though the association with N. gonorrhoeae was difficult
to ascertain due to its low prevalence in this group (Table S1).
Additionally, we saw no difference in hormonal contraceptive
method, condom use, or reported sexual activity (Table S1).Immunity 42, 965–Thus, there was no evidence that the
high ecological diversity in CT4 was
due to behavioral, infectious, or exoge-
nous hormonal etiologies.
Large Variation in Baseline Genital
Immune Activation Is Not Explained
by STIs
Genital immune activation has been
described as an important risk factor fordisease of the FGT, such as obstetric complications (Inglis
et al., 1994; Lockwood et al., 1994) and HIV acquisition (Lajoie
et al., 2012; Masson et al. 2015; Morrison et al., 2014). We there-
fore assessed the cohort’s baseline genital immune activation
by measuring the concentrations of 17 soluble cytokines in cer-
vicovaginal lavage (CVL) fluid from all participants who had
completed at least one mucosal sampling. The cytokine panel
included canonical pro-inflammatory cytokines (interleukin-1a
[IL-1a], IL-1b, tumor necrosis factor alpha [TNF-a]), interferons
(IFN-g, IFN-a2), chemokines (MIP-1a, MIP-1b, RANTES, IP-10,
IL-8), regulators of inflammation (IL-1 receptor antagonist [IL-
1RA], IL-10), differentiation markers (IL-4, IL-12p70), and activa-
tion and proliferation markers (soluble CD40L, FLT-3L, IL-2).
There was a wide range in CVL pro-inflammatory cytokine levels,
with over a 1,000-fold difference in some cytokines (e.g., IL-8
and IL-1a) among participants. We performed unsupervised
clustering to visualize inflammatory patterns (Figure 3A) and
found strong positive correlations (Spearman’s p > 0.4) between
45% of cytokine pairs (Figure S3A).
To reduce the dimensionality of the cytokine dataset to a
smaller number of covarying components, we performed prin-
cipal component analysis (PCA) on the normalized cytokine
concentrations. We found that the first principal component
(PC1) explained 41% of the variation in cytokines; PC1 repre-
sented the general presence of inflammatory cytokines, with
high and nearly equal loading by all cytokines except for IL-
1RA and IP-10, which had a negligible contribution (Figure S3B).
We next asked whether women with the highest levels of
cytokine inflammation had active STIs. Chlamydia trachomatis
was the most prevalent STI in this cohort, with 13% of women
testing positive at the first visit. We found that women with
C. trachomatis had higher inflammation than women without
an STI (p = 0.0226, Mann-Whitney test) but saw no trend with
N. gonorrhoeae (Figures S3C–S3E), consistent with previous
studies (Hedges et al., 1998; Rasmussen et al., 1997). Of the
35 women in the top quartile of inflammation, 75% of them did
not have a detectable STI (Figure 3B). Cytokine levels also did976, May 19, 2015 ª2015 Elsevier Inc. 967
Figure 3. Asymptomatic Women Display a Broad Range of Baseline Genital Inflammation that Is Not Explained by STIs
(A) Heatmap of cervicovaginal lavage cytokines from 146 women, each represented by a column. Nugent scores and active STIs (blue: C. trachomatis,
N. gonorrhoeae, T. vaginalis, and/or HSV-2 positive; gray: negative for that STI) are also displayed. Principal component (PC) analysis was performed on the
normalized cytokine concentrations and the first PC (PC1) explained 41% of variation.
(B) Pie chart of the STI prevalence in women in the highest quartile of inflammation (n = 35).
See also Figure S3 and Table S2.not correlate with sexual frequency, condom use, hormonal
contraception use, or self-reported STI symptoms (Fisher’s
exact test with p = 0.05 significance level, Table S2). Thus, the
cause of elevated genital inflammation in the majority of women
remained unexplained.
High-Diversity Bacterial Communities Are Strongly
Associated with Pro-inflammatory Genital Cytokines
To assess whether microbial communities might account for
non-STI associated genital inflammation, we compared genital
pro-inflammatory cytokine levels among CTs, with the hypoth-
esis that Lactobacillus crispatus dominant CT1 would have
the lowest inflammation due to the beneficial effects attributed
to L. crispatus (Ghartey et al., 2014). To determine aggregate
differences in cytokine concentrations, we first examined
the value of cytokine PC1 in each CT. There was a highly sig-
nificant difference across the cervicotypes (p < 0.0001); be-
tween CT1 and CT4 (p < 0.01); CT2 and CT4 (p < 0.001), and
between CT3 and CT4 (p < 0.05) (Kruskal-Wallis with post-
test, Figure 4A), even after excluding women with any STIs
(Figure S4A).
To determine how strongly the presence of CT4, STIs, or BV
associated with inflammation (defined by highest quartile of
cytokine PC1), we calculated the odds ratios for each and found
that only CT4 was significantly associated with cytokine PC1
(OR 4.33, 95% CI: 1.575 –11.92; p = 0.0046), though there968 Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc.was a trend for PCR-positive chlamydia (OR 2.380, 95% CI:
0.8497 – 6.666; p = 0.1329) (Figure 4B). This indicated that
women with CT4 were over four times more likely to have
elevated genital pro-inflammatory cytokines than those with
CT1–CT3, and that CT4 was a better predictor of inflammation
than STIs or BV.
We next determined which of the cytokines that comprise PC1
were different between CTs. We observed significant increases
in IL-1a, IL-1b, TNF-a, IFN-g (p < 0.001, Figures 4C–4F), IL-10
(p < 0.01, Figure 4G), and IL-8 (p < 0.05, Figure 4H), as well as
IL-12p70, IL-4, and FLT-3L (p < 0.01, Figures S4B–S4D) in CT4
relative to CT1. Even after excluding women with any STIs, indi-
viduals with CT4 still had significantly higher levels of each of
these cytokines relative to those with CT1 (Figures S4E–S4M).
We observed a less pronounced increase in cytokines in CT3,
with significantly higher IFN-g than CT1, and a trend toward
higher TNF-a, IL-8, and IL-10. Thus, the highly diverse bacterial
communities in CT4, and to a lesser extent CT3, were strongly
associated with the presence of multiple pro-inflammatory cyto-
kines, suggesting that specific genital bacteria could induce a
robust local immune response.
Longitudinal Changes in Genital Microbial Communities
Correlate with Pro-inflammatory Cytokines
Because of the close association between genital bacterial
communities and inflammation in the cross-sectional analysis,
Figure 4. Genital Pro-inflammatory Cytokine Levels Vary Significantly withMicrobial Community Structure andMost Strongly Correlate with
CT4 Bacterial Communities
(A) Cytokine PC1 values from women with bacterial communities CT1–CT4.
(B) Odds ratios and 95% confidence intervals representing the likelihood that a woman with cervicotype 4, an active chlamydia infection, bacterial vaginosis
(Nugent score > 7), an active Trichomonas infection, or cervicotype 3 is within the top quartile of pro-inflammatory cytokine levels (as determined by cytokine PC1)
versus below the 75th percentile.
(C–H) Cervicovaginal lavage IL-1a, IL-1b, TNF-a, IFN-g, IL-10, and IL-8 concentrations in women with bacterial communities CT1-4. Median and IQR are shown.
Significance levels were determined by a Kruskal-Wallis test, and asterisks denote post-test significance level (*p < 0.05; **p < 0.01; ***p < 0.001; n = 94). See also
Figure S4.we assessed the stability of these factors over time. We per-
formed 16S rRNA sequencing and measured soluble cyto-
kines on matched longitudinal cervical swabs and CVLs
from all women who had been followed for 6–12 months at
the time of analysis. In 58% of sequential time points, women
remained in the same CT (Figure S5A). Of those who had
changes in microbial communities, there was a close associ-
ation between CTs and IL-1a, IL-1b, and TNF-a, which we
focused on because they had the strongest associations
with CTs in the cross-sectional analysis. Two representative
individuals who experienced CT changes are shown in Fig-
ure 5A (also see Figure S5, and associated metadata in TableS3). When we assessed sequential time points for which there
was not a CT change, we did not find a significant difference
in the canonical pro-inflammatory cytokines (p > 0.05, one-
tailed Wilcoxon matched pairs test; Figure 5B). However,
there were significant increases in IL-1a (p = 0.033), IL-1b
(p = 0.042), and TNF-a (p = 0.030) in adjacent time points
with transitions between a lower and higher CT (one-tailed
Wilcoxon matched pairs test; Figure 5C). Thus, intra-individ-
ual changes in genital bacterial communities were tightly
linked to inflammatory changes and further support the recip-
rocal relationship between bacterial communities and genital
inflammation.Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc. 969
Figure 5. Intraindividual Longitudinal Genital Microbiome Changes Correlate with Pro-inflammatory Cytokine Levels
(A) Cervicovaginal IL-1a, IL-1b, and TNF-a concentrations with bacterial taxa identified by 16S rRNA sequencing from matched longitudinal cervical swabs and
CVLs collected from two representative participants, #13 and #14.
(B and C) Cervicovaginal IL-1a, IL-1b, and TNF-a concentrations from serial time points with either no change in CT (B) or a change (C) (one-tailed Wilcoxon
matched pairs test). The order of time points was standardized such that the lower cervicotype was entered as the first time point and the higher cervicotype was
entered as the second time point, regardless of the actual chronological order. Any transition, e.g., from CT1 to CT2 and fromCT3 to CT4, was considered to be a
CT change.
See also Figure S5 and Table S3.Identification of Bacterial Species that Cause
Pro-inflammatory Cytokine Secretion
We next asked which bacteria in CT4 were most highly
correlated with inflammation. To select bacterial taxa to use
in a multivariate model, we performed univariate Spearman cor-
relations between cytokine PC1 and each taxon found with over
0.1% abundance (Figure S6A). The 11 taxa with highly significant
correlations (p% 0.005) were included as predictor variables in
the multivariate analysis. Because many taxa were highly corre-
lated (Figure S6B), the ridgemethod was used to correct for mul-
ticollinearity and revealed six genera significantly correlated with
cytokine PC1: Fusobacterium, Aerococcus, Sneathia, Gemella,
Mobiluncus, and Prevotella (Figure 6A). Species-level identifica-
tion fromwhole-genome sequencing (Figure S2A) provided a set
of candidate bacteria to test in vitro.970 Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc.We used these candidates to test the causative relationship
between individual bacterial species and genital inflammation
with an in vitro epithelial cell co-culture assay, because epithe-
lial cells play critical roles as anatomic barriers and in the innate
immune response to bacteria in the FGT (Fichorova et al., 2011;
Wira et al., 2005). We co-cultured immortalized human vaginal
epithelial cells with bacterial isolates and measured secreted
pro-inflammatory cytokines in the supernatant. Consistent
with our in vivo findings, Prevotella amnii, Mobiluncus mulieris,
Sneathia amnii, and Sneathia sanguinegens induced higher
levels of IL-1a, IL-1b, and IL-8 than Lactobacillus crispatus (Fig-
ures 6B–6E, Table S4). Prevotella, the genus consistently pre-
sent in CT4, was able to induce significant cytokine secretion
even at an input colony-forming unit (CFU) as low as 2 log10 (Ta-
ble S4). Additionally, L. iners induced moderate IL-8 secretion,
Figure 6. Bacterial SpeciesHighly Correlatedwith Pro-inflammatory
Cytokines In Vivo Also Stimulate Vaginal Epithelial Cells to Produce
the Same Cytokines In Vitro
(A) Ridge regression analysis with cytokine PC1 as the response variable and
bacterial abundances as the predictor variables. The bacterial prevalence
among the 94 subjects is also shown; taxa must have an abundance of at least
1% within a sample to be considered present.
(B–E) IL-1a, IL-1b, TNF-a, and IL-8 secretion by vaginal epithelial cells after
in vitro application of 15 log10 CFU/cm
2 of each bacterial species. MALP-2 (a
TLR 2/6 agonist; 25 nM) treatment was used as a positive control (value de-
noted by dashed line). p values were determined by a Dunnett test, compared
to Lactobacillus crispatus. Data are shown as mean and SEM, with two bio-
logical replicates.
See also Figure S6 and Table S4.consistent with reports that it can have moderate pro-inflamma-
tory activity, whereas L. crispatus and Aerococcus christensenii
did not elicit any cytokine secretion relative to the absence of
bacteria. Low levels of TNF-a were detected in response to
these bacteria. These data suggest that epithelial cells sense
cervicovaginal bacteria in a species-specific manner and con-
tribute to the observed pro-inflammatory cytokines found in
women in CT4.
Genital APCs from Women with High-Diversity Genital
Communities Are Activated by Microbial Products
In Vivo
APCs in the cervix are closely associated with the epithelium
(Figures 7A and 7B) and sense microbes in conjunction with
epithelial cells (Hickey et al., 2011). Because the context in which
APCs are stimulated can have important effects on their pheno-
type and ability to prime adaptive immune cells (Littman and
Pamer, 2011; Ochiel et al., 2010), we performed phenotypic
and transcriptional analyses on sorted APCs obtained by cervi-
cal cytobrush to understand bacterial sensing in situ (Fig-
ure S7A). We compared APCs from women in CT1 or CT2,
who had gram-positive Lactobacillus dominance, to those in
CT4, additionally excluding anyone with an active STI. Using
flow cytometry, we saw no significant difference in the frequency
of cervical APC subsets (CD11c+ dendritic cells or CD14+ mono-
cytes or macrophages) (Figure S7B). However, there were pro-
nounced transcriptional differences among the cervical APCs;
35 genes were significantly upregulated and two were downre-
gulated inwomenwithPrevotella-dominant communities relative
to those with Lactobacillus dominance (false discovery rate
[FDR] < 0.05; Figures 7C and S7C). The genes upregulated in
CT4 were enriched in NF-kB, Toll-like receptor (TLR), NOD-like
receptor, and TNF-a signaling pathways. Gene set enrichment
analysis revealed that 20 of the 35 genes upregulated in CT4
APCs were shared with monocytes treated with a low dose of
LPS (a TLR4 agonist; q = 6.16e-36) and 19 genes were shared
with dendritic cells treated with LPS (q = 1.11e-33). Ingenuity
Pathway Analysis also identified LPS as themost likely upstream
regulator to be activated in CT4 APCs (p = 9.47e-26). These re-
sults are consistent with our bacterial pathway analysis using the
microbial DNA shotgun sequences, which demonstrated that
LPS biosynthesis was the second most enriched pathway in
the high inflammation samples compared to those with low
inflammation (Table S5).
In addition to LPS, Ingenuity Pathway Analysis also predicted
IFN-g (p = 6.31e-24), IL-1b (p = 1.51e-23), and CSF2 (colony
stimulating factor 2, p = 6.74e-22) to be upstream regulators
of the CT4 APCs, which was consistent with higher levels of
IFN-g and IL-1b in the CVLs of womenwith CT4. Also consistent
with the CVL cytokine measurements, CT4 APCs had signifi-
cantly higher expression of many pro-inflammatory cytokine
genes, such as IL1A (5.8-fold), IL1B (4.3-fold), TNF (6.5-fold),
IL10 (10.6-fold), IFNB1 (23.4-fold), IL23A (7.3-fold), and IL6
(8.9-fold), compared to CT1 and CT2 APCs (Figure 7C). Of rele-
vance to cellular recruitment, CT4 APCs also upregulated the
chemokines CCL4 (MIP-1b, a CCR5 ligand, 5.7-fold), CXCL9
(MIG, a CXCR3 ligand, 9-fold), and CCL8 (MCP-2, a CCR1
and CCR5 ligand, 6.3-fold). These transcriptional differences
were not observed when comparing APCs from peripheralImmunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc. 971
Figure 7. Cervical APC Sensing of Genital Bacteria
Transcriptional profiling suggests that CT4 bacterial products are sensed by cervical APCs, which contribute to genital inflammation by producing a myriad of
pro-inflammatory cytokines and critical T cell chemoattractants.
(A and B) CD14 (A) and CD11c (B) staining of endocervical tissue. Scale bar represents 50 mm.
(C) Heatmap of genes differentially expressed in cervical APCs from women with Lactobacillus-dominant communities (> 95% abundance; from left to right: 2 in
CT1, 3 in CT2) versus those with high Prevotella abundance (> 25%; n = 5 in CT4). Women with STIs were excluded. Only genes with a false discovery rate < 0.05
are shown. GSEA was used to determine statistically significant similarities with annotated gene sets.
(D) Number of live endocervical CD38+ HLADR+ CCR5+ CD4+ T cells from women in the highest and lowest quintile of cytokine PC1 (Mann-Whitney, n = 16 per
group). Data shown as Tukey box plots.
See also Figure S7 and Table S5.blood between CTs (Figure S7C). Thus, the transcriptional pro-
file of cervical APCs indicated that they were responding to a
CT4 bacterial product such as LPS and subsequently initiating
acute inflammation and lymphocyte recruitment and that these
differences were not a reflection of systemic inflammatory
activation.
Women with Elevated Pro-inflammatory Genital
Cytokines Have Increased Activated Cervical HIV Target
Cells
Given the close linkage between CT4 bacteria and genital
inflammation, we sought to determine whether pro-inflamma-
tory cytokines would correlate with the presence of activated972 Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc.HIV target cells in the genital tract. Activated CCR5+ CD4+
T cells at the cervical mucosal surface are likely the first suscep-
tible cells to encounter HIV upon sex with an infected partner
(Haase, 2010) and support greater HIV replication upon infec-
tion than resting cells (Meditz et al., 2011). We found a signifi-
cantly higher number of activated (CD38+ HLA-DR+) CCR5+
CD4+ T cells in the endocervical canal of women in the top quin-
tile of cytokine PC1 relative to those in the bottom quintile (p =
0.0361, Figure 7D), but no significant difference in activated
CCR5+ CD4+ T cells in the peripheral blood (Figure S7D).
Thus, the observed increase in genital HIV target cells supports
the link between high-diversity microbial communities and HIV
acquisition risk.
DISCUSSION
By integrating metagenomic, immunologic, transcriptional, and
behavioral datasets from a population of young South African
women, we demonstrated a strong link between high-diversity
cervicovaginal bacterial community structures and genital in-
flammation in vivo in both cross-sectional and longitudinal ana-
lyses. Women with CT4 were over four times more likely to have
high pro-inflammatory genital cytokine levels than those with
other CTs and, on average, had higher levels of genital inflam-
mation than women with BV or STIs. We provide evidence
that these high-diversity communities in the FGT are sensed
by both epithelial cells and APCs. APCs specifically appear to
respond to LPS via Toll-like receptor 4 signaling, contributing
to genital inflammation through NF-kB activation and recruit-
ment of lymphocytes by chemokine production. This was
consistent with the bacterial pathway analysis that demon-
strated that LPS biosynthesis was highly enriched in bacterial
communities from women with high genital inflammation. This
genital inflammation was accompanied by increased numbers
of activated HIV infectable CD4+ T cells in the cervix, providing
a potential cellular link to increased HIV acquisition risk. Our
study therefore identified a mechanism by which the predomi-
nant cervicovaginal communities found in our cohort of South
African women impact genital inflammation and thereby likely
modulate HIV acquisition risk.
Only 37% of participants had CT1 or CT2 bacterial commu-
nities, clearly indicating that Lactobacillus dominance was not
typical in this population. This is in contrast to studies in the
U.S., in which 90%of white womenwere found to have Lactoba-
cillus dominance (Ravel et al., 2011), but consistent with previous
studies that useGram stain analyses to demonstrate a high prev-
alence of BV in sub-Saharan African women (Jespers et al.,
2014; Myer et al., 2005). We reported a common occurrence
of low Lactobacillus, high-diversity communities even in the
absence of BV and provided a comprehensive characterization
of bacterial taxa by using high-throughput sequencing.
The etiology of the low Lactobacillus abundance in our cohort
remains unexplained. It was not associatedwith sexual behavior,
contraceptive usage, or demographic characteristics, and we
speculate that host genetic factors might play a role. Previous
studies demonstrate a lower frequency of L. crispatus and
L. jensenii and a higher frequency of Prevotella in black and His-
panic women compared to white and Asian women in the U.S.
(Ravel et al., 2011; Zhou et al., 2007). The high-diversity vaginal
communities seen in black American women show general sim-
ilarities to those seen in black South African women, specifically
with high levels ofPrevotella, but the prevalence of these high-di-
versity communities was approximately half of that observed in
South Africans. Studies of African cohorts have also demon-
strated a higher intestinalPrevotella abundance than in American
and European cohorts (De Filippo et al., 2010; Yatsunenko et al.,
2012) suggesting that vaginal seeding from the bacteria-rich
rectum (El Aila et al., 2009) might also influence the observed
differences. Overall, our findings support the growing under-
standing that Lactobacillus dominance is not tantamount to a
‘‘healthy’’ female genital tract microbiome in all women (Ravel
et al., 2011), and they highlight the value of bacterial character-
ization in broader geographic regions.Within CT4, we found that Sneathia sanguinigens, Sneathia
amnii, Mobiluncus mulieris, and Prevotella amnii were capable
of inducing the secretion of IL-1a, IL-1b, and IL-8 from human
vaginal epithelial cells in vitro.Aerococcuswas highly associated
with inflammation in vivo but did not induce cytokine secretion
in vitro, possibly due to the particular bacterial isolate that we
tested or because it is merely well-adapted to surviving in in-
flamed tissue, but not a primary driver of inflammation. We did
not test Fusobacterium, but Fusobacterium nucleatum has
been shown to be pro-inflammatory and tumorigenic in the gut
(Kostic et al., 2013). Overall, several CT4 bacteria were capable
of directly inducing pro-inflammatory cytokine production from
epithelial cells in vitro. The strong correlation between bacterial
communities and genital inflammation that we demonstrated
might help explain the increased genital immune activation
seen in other sub-Saharan cohorts compared to those in the
U.S. (Cohen et al., 2010). While the proportion of American
women with high-diversity communities might be lower, prelim-
inary results demonstrated that they were also associated with
elevated pro-inflammatory genital cytokines (data not shown).
To begin to understand how CT4 bacteria are sensed by the
host immune system, we performed transcriptional analyses
on APCs isolated from cervical cytobrushes. APCs from women
with high Prevotella abundance demonstrated a marked res-
ponse to LPS, as well as to IFN-g and IL-1b. This most likely re-
flects both the stimulation by gram-negative bacteria and effects
of the cytokine milieu, because women with CT4 had higher
levels of both IFN-g and IL-1b in the CVL. The CT4 APCs also
were more activated and mature, with higher expression of
CD80, ICAM-1, and MHC II and were likely contributing to both
T cell priming and effector function control (Iijima et al., 2011).
Additionally, miR-155 was strongly upregulated in CT4 APCs
and has been shown previously to be critical for APCs to effec-
tively activate T cells (Rodriguez et al., 2007).
Based upon transcriptional data and in vitro assays, we pro-
pose that cervicovaginal bacteria are sensed through epithelial
cells and APCs, activating TLR and NF-kB pathways that cause
secretion of chemokines that recruit activated CCR5+ CD4+
T cell targets to the genital tract. Additionally, cytokines such
as TNF-a and IFN-gmight directly damage the columnar epithe-
lial barrier of the endocervix by disrupting tight junctions, which
enables both bacterial and viral translocation (Madara and Staf-
ford, 1989; McGee et al., 1992). Thus, bacteria-induced genital
inflammation might increase HIV acquisition through multiple
local mechanisms in the FGT. This is supported by prior obser-
vations that pro-inflammatory cytokines in CVLs are associated
with an over 3-fold increased risk of HIV acquisition in women
(Masson et al., 2015) and that HIV-1 exposed women who
remain seronegative have lower levels of genital IFN-g, IL-1a,
and IP-10 (Lajoie et al., 2012).
Our work supports the role of the bacterial microbiome in
modulating HIV risk and suggests that interventions targeting
genital microbiota, such as narrow-spectrum antibiotics or pro-
biotics, might reduce HIV acquisition in women. In addition,
our results indicate that the genital microbiome can significantly
alter local host inflammation and might more broadly impact ef-
forts to create effective microbicides, induce mucosal vaccine
responses, curtail cervical cancer progression, and improve
reproductive health in women.Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc. 973
EXPERIMENTAL PROCEDURES
Study Cohort
Participants were recruited through the Females Rising through Education,
Support, and Health (FRESH) study, a prospective, 12-month observational
study of women 18–23 years old conducted outside of Durban, South Africa.
At the time of data analysis, 146 participants had completed at least one
mucosal sampling. The study protocol was approved by the Biomedical
Research Ethics Committee of the University of KwaZulu-Natal and the Mas-
sachusetts General Hospital Institutional Review Board (2012P001812/MGH).
Informed consent was obtained after the nature and possible consequences of
the study were explained.
Sample Collection
Twice weekly volunteers had a finger-prick blood draw for HIV RNA testing
and every 3 months had a pelvic exam, peripheral blood draw, and
completed an HIV risk questionnaire administered by a counselor. The
mucosal sample collection involved the collection of ectocervical and
midvaginal swabs (Catch-All, Epicenter), a cervicovaginal lavage, and an
endocervical cytobrush, as described in the Supplemental Experiment
Procedures.
BV and Sexually Transmitted Infection Detection
Vaginal smear Gram staining, Nugent scoring for BV, and STI testing were per-
formed by Global Labs.
Bacterial 16S rRNA Gene Sequencing
Nucleic acid was extracted from cervical swabs by bead beating in
phenol:chloroform:isoamyl alcohol (25:24:1, pH 7.9, Ambion), followed by an
isopropanol precipitation, as described in the Supplemental Experimental
Procedures. Extracted DNA was amplified with the 16S rRNA gene V4 primer
constructs (Caporaso et al., 2012) 515F and Golay-barcoded 806R for PCR
amplification and Illumina sequencing. The cleaned amplicon pool was
sequenced on a single 1 3 300 bp run on an Illumina MiSeq machine. 16S
rRNA sequencing reads were processed with the QIIME (Caporaso et al.,
2010) version 1.8.0 analysis pipeline. Samples from the full dataset were
then assigned to the four cervicotypes based on a simple assessment of domi-
nance (i.e., abundance). Details can be found in Supplemental Experimental
Procedures.
Metagenomic Shotgun DNA Sequencing and Taxonomic
Classification
Shotgun DNA libraries were made from total nucleic acid isolated from 12 cer-
vical swab samples; the same total nucleic acid was used for 16S rRNA amplif-
ication. DNA was isolated from the total nucleic acid with an AllPrep DNA/RNA
Micro Kit (QIAGEN) and sheared (S2 sonicator, Covaris). DNA libraries were
prepared with the NEBNext DNA Library Construction kit (New England Bio-
labs) and sequenced on a single paired-end 250 bp Illumina MiSeq run. Bac-
terial species were identified with the MetaPhlAn2 package v.2.0.0.b (Segata
et al., 2012).
Bacterial Functional Pathways Analysis
Reads aligning to the human genome or PhiX were removed from quality
controlled and adaptor trimmed shotgun DNA sequences. The remaining
reads were assigned to KEGG genes via a translated BLAST search, and
HUMAnN was used to identify the differentially abundant microbial pathways
(Abubucker et al., 2012).
Cytokine Measurements in CVLs
Cytokines were measured by a human cytokine/chemokine multiplexed bead
assay (Millipore). CVLs were analyzed within 6 months of collection and under-
went a single freeze-thaw cycle. Additional information can be found in the
Supplemental Experimental Procedures.
Bacterial Strains and Colonization Assays
Isolates were obtained from the Culture Collection University of Go¨teborg, the
American Type Culture Collection (ATCC), and collaborators. See Supple-
mental Experimental Procedures for further information.974 Immunity 42, 965–976, May 19, 2015 ª2015 Elsevier Inc.Immunophenotyping of Cervical Cytobrush Samples
Cervical and peripheral blood cells were stained with a violet viability dye (Life
Technologies) and labeled with a cocktail of antibodies, described in detail in
the Supplemental Experimental Procedures. Cells were sorted on a FACS Aria
III (BD Biosciences) directly into TRIzol (Life Technologies), vortexed vigor-
ously, and stored at 80C. Data were processed with FlowJo software
(Tree Star). See Figure S7A for gating strategy.
Transcriptional Analysis of Sorted Cells
RNA was extracted from cells sorted into TRIzol by a chloroform-based
method. RNAquality and quantity were assessedwith the Bioanalyzer (Agilent)
and RINs were consistently above 9. The RNA-seq libraries were prepared ac-
cording to the Single Cell RNA Barcoding and Sequencing method originally
developed for single cell RNA-seq (SCRB-seq; Soumillon et al., 2014) and
adapted to extracted total RNA. Digital gene-expression values were analyzed
with the edgeR package (Robinson et al., 2010).
Statistics
Mann-Whitney Wilcoxon test was used to compare continuous data between
two groups. For comparisons between more than two groups, Kruskal-Wallis
test with post hoc analyses was used. Wilcoxon signed rank was used to
compare continuous data between two time points. Fisher’s exact test was
used for comparing categorical data among two or more groups. Spearman’s
correlation coefficients were used to examine associations between variables;
only correlations with a p value lower than the specified cutoff are displayed.
Principal component and cluster analyses were used to obtain summary mea-
sures for cytokine/bacteria variables and to identify study subjects with similar
cytokine/bacteria profiles. Multivariate analyses using ridge regression (Cule
and De Iorio, 2013) were used to identify the correlates of higher cytokine
values. p values are two-sided and are not adjusted for multiple testing. The
analyses were performed with R Studio and Prism (GraphPad).
ACCESSION NUMBERS
The accession number for the gene expression data reported in this paper is
GSE68452.
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Supplemental Information includes seven figures, five tables, and Supple-
mental Experimental Procedures and can be found with this article online at
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